SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to COVID-19. The emergence of hypermutated, increasingly transmissible variants of concern (VOCs) threaten this strategy. Omicron (B.1.1.529), the fifth VOC to be described, harbours multiple amino acid...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Willett, BJ, Grove, J, MacLean, OA, Klenerman, P, Dunachie, S, Barnes, E, Brown, A, Adele, S, Kronsteiner, B, Murray, SM, Abraham, P, Deeks, A, Ansari, MA, Fraser, C, Bonsall, D, Fryer, H, Lythgoe, K, Thomson, L, Golubchik, T, Underwood, AP, Taylor, BEW, Yeats, CA, Aanensen, DM, Abudahab, K, Menegazzo, M, Zarebski, AE, Gutierrez, B, Raghwani, J, du Plessis, L, Kraemer, MUG, Pybus, OG, Francois, S, Attwood, SW, Vasylyeva, TI, Trebes, A, Green, A, Buck, D, MacIntyre-Cockett, G, Todd, JA
Beste egile batzuk:	PITCH Consortium
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Springer Nature 2022
Gaiak:	molecular biology immunology vaccines viral infection

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Antzeko izenburuak